| 721 | HARRIS, GERI ADURHAM, NC · 27701 | EXECUTIVE DIRECTOR, TRANSFORMATION, ST · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $10 | Primary (P) | Filing 1937874FEC filing ↗ |
| 722 | MCCANN, EMILY SUZANNEDURHAM, NC · 27709 | SR ACCT SPEC, VIIV · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $10 | Primary (P) | Filing 1937874FEC filing ↗ |
| 723 | DELK, DEBBIE TAYLORDURHAM, NC · 27709 | VACCINE KEY ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $10 | Primary (P) | Filing 1937874FEC filing ↗ |
| 724 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXO SMITH KLINE | WARNOCK FOR GEORGIAC00736876 | 2025-12-04 | $10 | Primary 2028 (P2028) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1943738FEC filing ↗ |
| 725 | MATTHEWS, BRYANCHAPEL HILL, NC · 27514 | PHARMACEUTICALS · GSK | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-12-04 | $10 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1940014FEC filing ↗ |
| 726 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | FETTERMAN FOR PAC00765800 | 2025-11-28 | $10 | Primary 2028 (P2028) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1940988FEC filing ↗ |
| 727 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | JON OSSOFF FOR SENATEC00718866 | 2025-11-27 | $10 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1943025FEC filing ↗ |
| 728 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | FETTERMAN FOR PAC00765800 | 2025-11-27 | $10 | Primary 2028 (P2028) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1940988FEC filing ↗ |
| 729 | ADOFF, BRANDIFORT WASHINGTON, PA · 19034 | REGULATORY AFFAIRS · GSK | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-11-26 | $10 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1940014FEC filing ↗ |
| 730 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | MARK KELLY FOR SENATEC00696526 | 2025-11-25 | $10 | Primary 2028 (P2028) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1941700FEC filing ↗ |
| 731 | GRADY, CLEVELANDPHILADELPHIA, PA · 19104 | PRICING/REIMBURSEMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $10 | Primary (P) | Filing 1928923FEC filing ↗ |
| 732 | SPIES, CHRISTINA MARIEDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT ONCOLOGY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $10 | Primary (P) | Filing 1928923FEC filing ↗ |
| 733 | LONG, CYNTHIA M.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $10 | Primary (P) | Filing 1928923FEC filing ↗ |
| 734 | HELDER, MATTHEW BDURHAM, NC · 27709 | DIRECTOR, STATE GOVERNMENT AFFAIRS-PAC · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $10 | Primary (P) | Filing 1928923FEC filing ↗ |
| 735 | BURNS, DANIEL DCOLLEGEVILLE, PA · 19426 | SENIOR DIRECTOR, PROJECT MANAGEMENT AD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $10 | Primary (P) | Filing 1928923FEC filing ↗ |
| 736 | BOWMAN, DARIAN KATHLEENDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $10 | Primary (P) | Filing 1928923FEC filing ↗ |
| 737 | RAHMAN, IMRANDURHAM, NC · 27709 | FIRST LINE LEADER, RESPIRATORY - CO, W · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $10 | Primary (P) | Filing 1928923FEC filing ↗ |
| 738 | VAN HORSEN, DANIEL LEEDURHAM, NC · 27709 | VACCINE ECOSYSTEM LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $10 | Primary (P) | Filing 1928923FEC filing ↗ |
| 739 | BING-ZAREMBA, ADRIAN CHARLESPHILADELPHIA, PA · 19104 | DIRECTOR OMNICHANNEL BU ANALYTICS LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $10 | Primary (P) | Filing 1928923FEC filing ↗ |
| 740 | ACCIANI, THOMAS HENRYDURHAM, NC · 27709 | PUBLIC POLICY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $10 | Primary (P) | Filing 1928923FEC filing ↗ |